SGLT2 Inhibitors Tied to Better NAFLD Outcomes vs Other Antidiabetic Agents

(MedPage Today) -- In adults with both type 2 diabetes and nonalcoholic fatty liver disease (NAFLD), the use of SGLT2 inhibitors was linked to NAFLD regression and a lower incidence of poor liver-related outcomes, according to a retrospective cohort...
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news